UDC

[576.3+612.014+612.017.1]:616.43

DOI

10.37482/2687-1491-Z053

Authors

Svetlana V. Makarenko* ORCID: 0000-0002-1351-7581
Anna O. Drobintseva*/** ORCID: 0000-0002-6833-6243
Dmitriy S. Medvedev*/*** ORCID: 0000-0001-7401-258X
Irina I. Bode**** ORCID: 0000-0002-4893-852X
Aleksandr E. Andreev* ORCID: 0000-0003-3343-2937
Viktor R. Shumilkin* ORCID: 0000-0001-9201-4933
Viktoriya O. Polyakova* ORCID: 0000-0001-8682-9909

 *Saint-Petersburg Medico-Social Institute (St. Petersburg, Russian Federation)
**Saint-Petersburg State Pediatric Medical University (St. Petersburg, Russian Federation)
***North-Western State Medical University named after I.I. Mechnikov (St. Petersburg, Russian Federation)
****Saint-Petersburg State University (St. Petersburg, Russian Federation)

Corresponding author: Anna Drobintseva, address: ul. Litovskaya 2, St. Petersburg, 194100, Russian Federation; e-mail: anna.drobintseva@gmail.com

Abstract

The placenta is a unique organ that provides a normal functioning of foetus during the period of intrauterine development. However, in spite of its importance, the placenta remains poorly studied. Answers to the questions about immune interactions in the placenta can explain the development of many pregnancy complications. This paper studied age-related features of immunocompetent cell markers expression in the human placenta in normal and pathological conditions (type 2 diabetes mellitus, T2DМ). We examined villous chorion samples obtained from 80 patients: 40 subjects with type 2 diabetes mellitus and 40 control subjects. Each of the groups was further divided into the subgroups of primiparas and multiparas, as well as into age subgroups (births before and after 28 years). We selected CD68 (macrophage marker), CD20 (B-lymphocyte marker) and CD57 (NK-cell marker) as molecules of interest. The research revealed differences in the expression of immunocompetent cell markers between the group of patients with T2DМ and the control group as well as age-related differences in the expression of these markers within the groups. In addition, we were able to study the morphofunctional state of the placentas. It is known that signalling molecules produced by immune cells play a key role in the pathological processes that can take place during pregnancy. The results obtained indicate a high epidemiological and scientific importance of inflammatory markers in assessing the gestation course and the possible development of somatic pathology in newborns, especially in women aged 28 or older.
For citation: Makarenko S.V., Drobintseva A.O., Medvedev D.S., Bode I.I., Andreev A.E., Shumilkin V.R., Polyakova V.O. Morphofunctional features of immunocompetent cells in the human placenta from patients with type 2 diabetes mellitus. Journal of Medical and Biological Research, 2021, vol. 9, no. 2, pp. 153–162. DOI: 10.37482/2687-1491-Z053

Keywords

placental immunocompetent cells, villous chorion, pregnancy, type 2 diabetes mellitus, agerelated changes in the placenta

References

1. Dedov I.I., Shestakova M.V., Vikulova O.K., Zheleznyakova A.V., Isakov M.A. Sakharnyy diabet v Rossiyskoy Federatsii: rasprostranennost’, zabolevaemost’, smertnost’, parametry uglevodnogo obmena i struktura sakharosnizhayushchey terapii po dannym federal’nogo registra sakharnogo diabeta, status 2017 g. [Diabetes Mellitus
in Russian Federation: Prevalence, Morbidity, Mortality, Parameters of Glycaemic Control and Structure of Glucose Lowering Therapy According to the Federal Diabetes Register, Status 2017]. Sakharnyy diabet, 2018, vol. 21, no. 3, pp. 144–159.
2. Kang Y.E., Kim J.M., Joung K.H., Lee J.H., You B.R., Choi M.J., Ryu M.J., Ko Y.B., Lee M.A., Lee J., Ku B.J., Shong M., Lee K.H., Kim H.J. The Roles of Adipokines, Proinflammatory Cytokines, and Adipose Tissue Macrophages in Obesity-Associated Insulin Resistance in Modest Obesity and Early Metabolic Dysfunction. PLoS One, 2016, vol. 11, no. 4. Art. no. e0154003. DOI: 10.1371/journal.pone.0154003
3. Pavela G., Kim Y.-I., Salvy S.-J. Additive Effects of Obesity and Loneliness on C-Reactive Protein. PLoS One, 2018, vol. 13, no. 11. Art. no. e0206092. DOI: 10.1371/journal.pone.0206092
4. Buschur E., Stetson B., Barbour L.A. Diabetes in Pregnancy. Feingold K.R., Anawalt B., Boyce A., et al. (eds.). Endotext. South Dartmouth, 2000. Available at: https://www.ncbi.nlm.nih.gov/books/NBK279010/ (accessed: 11 November 2019).
5. Groen in ’t Woud S., Renkema K.Y., Schreuder M.F., Wijers C.H.W., van der Zanden L.F.M., Knoers N.V.A.M., Feitz W.F.J., Bongers E.M.H.F., Roeleveld N., van Rooij I.A.L.M. Maternal Risk Factors Involved in Specific Congenital Anomalies of the Kidney and Urinary Tract: A Case-Control Study. Birth Defects Res. A Clin. Mol. Teratol.,
2016, vol. 106, no. 7, pp. 596–603. DOI: 10.1002/bdra.23500
6. Watkins M.L., Rasmussen S.A., Honein M.A., Botto L.D., Moore C.A. Maternal Obesity and Risk for Birth Defects. Pediatrics, 2003, vol. 111, no. 5, pt. 2, pp. 1152–1158.
7. Mor G., Cardenas I. The Immune System in Pregnancy: A Unique Complexity. Am. J. Reprod. Immunol., 2010, vol. 63, no. 6, pp. 425–433. DOI: 10.1111/j.1600-0897.2010.00836.x
8. Tabarkiewicz J., Selvan S.R., Cools N. Autoimmunity in Reproductive Health and Pregnancy. J. Immunol. Res., 2018, vol. 2018. Art. no. 9501865. DOI: 10.1155/2018/9501865
9. Turco M.Y., Moffett A. Development of the Human Placenta. Development, 2019, vol. 146, no. 22. Art. no. 163428. DOI: 10.1242/dev.163428
10. Kapustin R.V., Drobintseva A.O., Alekseenkova E.N., Onopriychuk A.R., Arzhanova O.N., Polyakova V.O., Kvetnoy I.M. Placental Protein Expression of Kisspeptin-1 (KISS1) and the Kisspeptin-1 Receptor (KISS1R) in Pregnancy Complicated by Diabetes Mellitus or Preeclampsia. Arch. Gynecol. Obstet, 2020, vol. 301, no. 2, рp. 437–445. DOI: 10.1007/s00404-019-05408-1
11. Aylamazyan E.K., Polyakova V.O., Lin’kova N.S., Kvetnoy I.M., Durnova A.O. Rol’ rezidentnykh immunnykh kletok v razvitii platsenty v norme i pri patologii [Role of Resident Immune Cells in the Development of the Placenta in Health and Disease]. Zhurnal akusherstva i zhenskikh bolezney, 2010, vol. 59, no. 6, pp. 8–14.
12. Jafar N., Edriss H., Nugent K. The Effect of Short-Term Hyperglycemia on the Innate Immune System. Am. J. Med. Sci., 2016, vol. 351, no. 2, pp. 201–211. DOI: 10.1016/j.amjms.2015.11.011
13. Moffett A., Loke Y.W. The Immunological Paradox of Pregnancy: A Reappraisal. Placenta, 2004, vol. 25, no. 1, pp. 1–8. DOI: 10.1016/S0143-4004(03)00167-X
14. Lei Q., Niu J., Lv L., Duan D., Wen J., Lin X. Clustering of Metabolic Risk Factors and Adverse Pregnancy Outcomes: A Prospective Cohort Study. Diabetes Metab. Res. Rev., 2016, vol. 32, no. 8, рp. 835–842.
15. Faas M.M., de Vos P. Uterine NK Cells and Macrophages in Pregnancy. Placenta, 2017, vol. 56, pp. 44–52. DOI: 10.1016/j.placenta.2017.03.001